Effect of a Protein-enriched Drink on Muscle Function (SPORTEUS)

March 10, 2015 updated by: Puleva Biotech

Effect of a Protein-enriched Drink on Muscle Function Recovery Following an Acute High Intensity Exercise Bout

There is no conclusive evidence about the effect of intake of protein-enriched drink after and acute high intensity exercise bout on muscle function and damage. The investigators aimed to study the effect of a protein-enriched drink on muscle function recovery following an acute high intensity exercise bout. The present counterbalanced, crossover, and double blind study will involve a total of 12 active men.

Study Overview

Status

Unknown

Conditions

Detailed Description

Participants will run downhill (-10%) during 30 min at a intensity equivalent to 75-80% of their maximum heart rate (previously determined). After the exercise bout, participants will have either the placebo or the experimental drink. The investigators will measure muscle function and damage-related parameters right after the exercise as well as the three following days. This protocol will be repeated after a wash out period of 3 weeks, where the participants will have the other drink. The investigators will control exercise and diet three weeks before study entry, during the experimental week as the investigators as during the wash out period.

Study Type

Interventional

Enrollment (Anticipated)

12

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Recreational triathletes with 2 years of experience
  • Maximum oxygen uptake : ≥55 ml/kg/min
  • Fat mass: 8-20% measured by dual energy x-ray absorptiometry
  • Not participating in another study
  • Not having ergogenic aids
  • Not participating in a weight loss program
  • Normal electrocardiogram
  • Participants must be capable and willing to provide consent, understand exclusion criteria and accept the randomized group assignment

Exclusion Criteria:

  • History of cardiovascular disease
  • Diabetes or hypertension
  • Medication for hypertension, hyperlipidemia, hyperuricemia or other illness.
  • Smoking
  • Other significant medical conditions that are life-threatening or that can interfere with or be aggravated by exercise.
  • Unwillingness to either complete the study requirements or to be randomized into control or training group.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
330 ml of commercial protein-enriched drink (2.5 g/100 ml of protein)
Experimental: Experimental
330 ml of protein-enriched drink (6 g/100 ml of protein)
Participants will drink 330 ml of a protein-enriched drink (6 g/ml of protein) after a high intensity exercise that induce muscle damage (30 min running downhill with a slope of -10º)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric muscle strength
Time Frame: Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Isometric muscle strength of lower limbs at 90% angle.
Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle soreness of lower limbs self-reported by a visual anagogic scale and with an algometer score.
Time Frame: Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Muscle soreness of the lower limbs will be self-reported by a visual anagogic scale and with an algometer score.
Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Power output assessed with the 30sec. Wingate anaerobic test
Time Frame: Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Power output will be assessed with the 30sec. Wingate anaerobic test.
Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Creatine kinase
Time Frame: Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
Creatine kinase will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout
Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
Urine Creatinine
Time Frame: Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
Concentration of creatinine in urine will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout
Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink
Resting metabolic rate
Time Frame: Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink
Time limit (time that the participant is able to run 90% of his determined maximum aerobic velocity)
Time Frame: 24hrs after protein-enriched drink
We will measure the time that the participant is able to run 90% of his determined maximum aerobic velocity
24hrs after protein-enriched drink

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Director: Federico Lara, PhD, Puleva Biotech

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Anticipated)

December 1, 2015

Study Completion (Anticipated)

December 1, 2015

Study Registration Dates

First Submitted

February 10, 2015

First Submitted That Met QC Criteria

March 10, 2015

First Posted (Estimate)

March 11, 2015

Study Record Updates

Last Update Posted (Estimate)

March 11, 2015

Last Update Submitted That Met QC Criteria

March 10, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • Puleva

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contracture

Clinical Trials on Protein-enriched drink

Subscribe